No Data
No Data
As of now, the total amount of cash dividends implemented by Zhejiang Wolwo Bio-pharmaceutical (300357.SZ) is nearly 800 million yuan.
Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) stated on the investor interaction platform that distributing cash dividends to shareholders is an important way to repay them. Since going public, the company has distributed profits in the form of cash every year, which exceeded 30% of the net income attributable to shareholders of the listed company that year, returning to all shareholders. Up to now, the total amount of cash dividends implemented by the company is nearly 0.8 billion yuan.
Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): Sales revenue of 821 million yuan in 2023 for dust mite drops.
On July 3rd, Gelunhui reported that Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) stated on its investor interaction platform that in 2023, the sales revenue of the company's product "Dust Mite Drops" was 821,023,791.81 yuan, and the sales revenue of "Artemisia Pollen Allergen Sublingual Drops" was 15,309,350.43 yuan.
Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): As of December 31, 2023, the company's cumulative cash dividend paid has exceeded RMB 700 million.
Zhejiang Wolwo Bio-pharmaceutical (300357.SZ) stated on the investor interactive platform that cash dividends are an important way to reward shareholders, and since its listing, the company has distributed profits in cash each year that are more than 30% of the net income attributable to shareholders of the listed company in that year, returning to all shareholders. As of December 31, 2023, the total amount of cash dividends implemented by the company has exceeded 700 million yuan, which is equivalent to about three times the amount of funds raised in the initial public offering.
Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) annual equity distribution in 2023: RMB 1.85 per 10 shares, with stock rights registration on July 3.
Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) announced that the annual equity distribution plan for 2023 is based on the total existing share capital of the company. All shareholders will receive RMB 1.85 in cash (including tax) for every 10 shares. The record date for this equity distribution is July 3, 2024, and the ex-dividend date is July 4, 2024.
Ge Longhui Fund Daily | Zhu Shaoxing, Feng Liu have new developments!
Focus on the latest news in the fund.
Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
No Data